Evidence map›Paper›PMID 19096390›Full record

ReviewNature reviews. Immunology2009

Regulation of T-helper-cell lineage development by osteopontin: the inside story.

Harvey Cantor, Mari L Shinohara

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 147 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. TheNeural regeneration research · 2021
    Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Harvey CantorDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. Harvey_Cantor@dfci.harvard.edu
Mari L Shinohara
Duke Medical Center · USHarvard University · US

Funding

THE T-CELL RESPONSE TO ANTIGENR01AI048125 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY · 2000 to 2021
$5.1M
T CELL SUBPOPULATIONS IN TRANSPLANTATION IMMUNITYR37AI012184 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY · 1997 to 2006
$3.5M
Postdoctoral Training Program in Cancer ImmunologyT32CA070083 · NCI · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY · 1997 to 2012
$2.8M
NCI NIH HHS T32 CA070083NIAID NIH HHS R01 AI048125NIAID NIH HHS R37 AI012184
6 · The paper itself

Abstract

Studies of osteopontin (OPN)-dependent regulation of immune responses have focused on the cytokine activities of the secreted form of this protein. Recent evidence has revealed that an intracellular form of OPN expressed by dendritic cells regulates the expression of pro-inflammatory cytokines and the differentiation of T helper (T(H))-cell lineages. In this Opinion article, we discuss the properties of both OPN isoforms and their respective contributions to the immune response. We propose that cell-type-specific expression of secreted and intracellular OPN regulates the development of distinct effector T(H) cells, including that of T(H)1 and T(H)17 cells.

Indexed as

AnimalsAutoimmune DiseasesBacterial InfectionsCell LineageDendritic CellsHumansInterleukin-17Lymphocyte ActivationLymphopoiesisMacrophagesOsteopontinTh1 CellsT-Lymphocytes, Helper-InducerVirus DiseasesInterleukin-17Osteopontin

Identifiers

PMID19096390
PMCPMC2696694
OpenAlexW2039736385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.